DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pralmorelin
Pralmorelin
The 2021 List of Pharmacological Classes of Doping Agents and Doping Methods
UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
( 12 ) United States Patent
1 Advances in Therapeutic Peptides Targeting G Protein-Coupled
Growth Hormone Secretagogues: History, Mechanism of Action and Clinical Development
Pharmaceutical Appendix to the Tariff Schedule 2
Analysis of Growth Hormone-Releasing Peptides for Doping Control
Sermorelin Acetate: Summary Report
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Major League Baseball Players Association Office of the Commissioner of Baseball
(12) Patent Application Publication (10) Pub. No.: US 2016/0243197 A1 G00 Sens (43) Pub
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
( 12 ) United States Patent
Customs Tariff - Schedule
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Prohibited List 2021
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Ep 1297838 A1
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Customs Tariff - Schedule
Detection of Growth Hormone Releasing Peptides in Serum by A
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Customs Tariff - Schedule Xxi - 1
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
Prohibited Substances List
WO 2010/024870 Al
Orphan Drug Designations and Approvals List As of 06‐01‐2015 Governs July 1, 2015 ‐ September 30, 2015
Harmonized Tariff Schedule of the United States (2006) (Rev
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Orphan Drug Designations and Approvals List As of 12‐01‐2014
2020 Prohibited List
(12) Patent Application Publication (10) Pub. No.: US 2017/0121385 A1 Shah Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antibodies Products
Table 1. Examples of Currently Approved Peptide Therapeutic Drugs
Medicines Regulations 1984 (SR 1984/143)
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Ipamorelin Acetate for Growth Hormone Replacement Therapy
WO 2012/116453 Al 7 September 2012 (07.09.2012) P O P C T
LPGA Prohibited Substances List
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016
Peptides to Increase Growth Hormone